{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-audit-report-handling-and-capa-integration”
},
“headline”: “SOP for Audit Report Handling and CAPA Integration”,
“description”: “This SOP outlines step-by-step procedures for handling audit reports and integrating Corrective and Preventive Actions (CAPA) in clinical trials, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 23/12/2025
Standard Operating Procedure for Audit Report Handling and CAPA Integration
| SOP No. | CR/OPS/071/2025 |
| Supersedes | NA |
| Page No. | 1 of 34 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define procedures for handling audit reports and integrating Corrective and Preventive Actions (CAPA) in clinical trials. Proper documentation and CAPA management
Scope
This SOP applies to sponsors, CROs, QA auditors, investigators, and clinical operations staff responsible for audit report preparation, communication, CAPA planning, and closure. It covers sponsor audits, CRO/vendor audits, site audits, and system audits across multi-regional clinical trials.
Responsibilities
- Auditor: Prepares objective audit reports, classifies findings, and submits reports within defined timelines.
- QA Manager: Reviews audit reports, ensures accuracy, and approves distribution.
- PI/Site: Responds to findings with CAPA plans and evidence of implementation.
- Sponsor/CRO: Ensures audit reports are filed, CAPAs are tracked, and closure is documented.
- Clinical Operations Manager: Monitors CAPA follow-up and verifies completion.
Accountability
The sponsor retains accountability for ensuring audit reports are documented, CAPAs are implemented, and closure is verified. QA ensures independence of the process, while investigators and vendors are accountable for timely corrective actions.
Procedure
1. Audit Report Preparation
Auditor prepares draft audit report within 10 working days of audit completion.
Report includes audit scope, methodology, findings (critical/major/minor), and supporting evidence.
Use standardized Audit Report Template (Annexure-1).
2. Internal Review and Approval
QA Manager reviews draft report within 5 working days.
Sponsor approves final report within 15 working days.
Final report filed in TMF and shared with auditee.
3. Communication to Auditee
Provide final audit report to PI/vendor/CRO within 20 working days.
Include CAPA request form for each finding (Annexure-2).
Auditee acknowledges receipt within 5 working days.
4. CAPA Development
Auditee submits CAPA plan within 20 working days.
Plan must address root cause, corrective action, and preventive action.
Sponsor QA reviews CAPA plan for adequacy.
5. CAPA Implementation and Tracking
Site/vendor implements corrective actions (e.g., retraining, SOP updates, reconciliation).
CRA verifies CAPA implementation during follow-up visits.
Document in CAPA Log (Annexure-3).
6. Closure of Findings
QA verifies CAPA effectiveness and records closure in Audit Finding Closure Log (Annexure-4).
Critical findings require independent QA approval prior to closure.
7. Escalation
Unresolved or ineffective CAPA must be escalated to sponsor senior management.
Document escalation in Audit Escalation Log (Annexure-5).
8. Archiving
Archive all audit reports, CAPA forms, logs, and closure records in TMF.
Retain for minimum 15 years or as per regulatory requirements.
Abbreviations
- SOP: Standard Operating Procedure
- CAPA: Corrective and Preventive Action
- QA: Quality Assurance
- TMF: Trial Master File
- PI: Principal Investigator
- CRO: Contract Research Organization
Documents
- Audit Report Template (Annexure-1)
- CAPA Request Form (Annexure-2)
- CAPA Log (Annexure-3)
- Audit Finding Closure Log (Annexure-4)
- Audit Escalation Log (Annexure-5)
References
- ICH E6(R2) – Good Clinical Practice
- FDA – Sponsor Audit Guidance
- EMA – Clinical Audit Guidelines
- CDSCO – Clinical Trial Audit Requirements
- WHO – Clinical Trial Audit Framework
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, QA Auditor |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Quality |
Annexures
Annexure-1: Audit Report Template
| Section | Details |
|---|---|
| Audit Scope | [Describe scope] |
| Audit Methodology | [Interview, document review, observation] |
| Findings | [Critical/Major/Minor] |
Annexure-2: CAPA Request Form
| Finding | Root Cause | Corrective Action | Preventive Action | Due Date |
|---|---|---|---|---|
| Incomplete consent form | Staff oversight | Retraining | SOP revision | 20/09/2025 |
Annexure-3: CAPA Log
| Date | Finding | CAPA | Responsible | Status |
|---|---|---|---|---|
| 12/09/2025 | IP accountability missing | Reconciliation + retraining | PI | Open |
| 14/09/2025 | SAE delay | Process updated | CRO | Closed |
Annexure-4: Audit Finding Closure Log
| Date | Finding | Evidence | Closed By | Status |
|---|---|---|---|---|
| 15/09/2025 | Consent incomplete | Corrected form filed | CRA | Closed |
| 17/09/2025 | Drug storage deviation | Revised SOP filed | QA Officer | Closed |
Annexure-5: Audit Escalation Log
| Date | Issue | Escalated To | Resolution | Closed By |
|---|---|---|---|---|
| 18/09/2025 | Repeated SAE delays | Sponsor Management | CAPA reinforced | QA |
| 19/09/2025 | Vendor data integrity concern | Head QA | Audit extended | Sponsor |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Quality |
For more SOPs visit: Pharma SOP